Evidence map›Paper›PMID 37533862›Full record

ArticleFrontiers in immunology2023

Multivalent vaccines demonstrate immunogenicity and protect against

Sharon Jan, Alycia P Fratzke, Jiin Felgner, Jenny E Hernandez-Davies, Li Liang, Rie Nakajima, Algimantas Jasinskas, Medalyn Supnet, Aarti Jain, Philip L Felgner and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Sterile protection againstLife science alliance · 2024
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sharon JanVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Alycia P FratzkeDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, TX, United States.
Jiin FelgnerVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Jenny E Hernandez-DaviesVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Li LiangVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Rie NakajimaVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Algimantas JasinskasVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Medalyn SupnetVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Aarti JainVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Philip L FelgnerVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
D Huw DaviesVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
Anthony E GregoryVaccine Research & Development Center, Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, United States.
University of California, Irvine · USTexas A&M Health Science Center · US

Funding

PROVIDE RABBITS, RATS, IMCE, HAMSTERS, GERBILS, AND GUINEA PIGS27307C0009 · NIEHS · PI MARSION, LESLIE · 2007 to 2007
$540k
NIEHS NIH HHS 27307C0009
6 · The paper itself

Abstract

Vaccines are among the most cost-effective public health measures for controlling infectious diseases.

Indexed as

Coxiella burnetiiAdjuvants, ImmunologicAerosolsAnimalsAntigensBacterial VaccinesGuinea PigsHumansLipopolysaccharidesMiceVaccines, CombinedAdjuvants, ImmunologicAerosolsAntigensBacterial VaccinesLipopolysaccharidesVaccines, Combinedadjuvantaerosol challengeCoxiella burnetiiguinea pighypersensitivitymultivalencyreactogenicitysubunit vaccine

Identifiers

PMID37533862
PMCPMC10390735
OpenAlexW4384666166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.